In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indonesia investigates new H5N1 source, as case-fatality soars:

This article was originally published in Clinica

Executive Summary

Indonesia is investigating the source of exposure of a fatal case of H5N1 avian flu from Tangerang, Banten province, according to an August 16 WHO update, citing the health ministry. To date, of the country's 104 officially-confirmed cases, 83 (80%) have been fatal. Indonesia's case-fatality rate is increasing far above the average of other countries: of this year's 29 officially-recorded cases, 25 have been fatal, equating to 86% case-fatality. In the rest of the world, of this year's 29 cases, 11 were fatal (38%); and of the 217 cases recorded since 2003, 111 were fatal (51%).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel